{{Rsnum
|rsid=2871776
|Gene=ATP13A2
|Chromosome=1
|position=17001806
|Orientation=minus
|GMAF=0.3884
|Gene_s=ATP13A2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 32.7 | 48.7 | 18.6
| HCB | 8.0 | 44.5 | 47.4
| JPT | 10.6 | 44.2 | 45.1
| YRI | 4.8 | 31.3 | 63.9
| ASW | 7.0 | 36.8 | 56.1
| CHB | 8.0 | 44.5 | 47.4
| CHD | 12.8 | 46.8 | 40.4
| GIH | 16.8 | 51.5 | 31.7
| LWK | 7.3 | 30.9 | 61.8
| MEX | 20.7 | 46.6 | 32.8
| MKK | 2.6 | 26.3 | 71.2
| TSI | 26.5 | 48.0 | 25.5
| HapMapRevision=28
}}{{PMID Auto
|PMID=22285144
|Title=ATP13A2 (PARK9) polymorphisms influence the neurotoxic effects of manganese
|OA=1
}}

{{on chip | Illumina Human 1M}}